News & Press: Advocacy

SIS Continues to Comment on Blue Shield of California’s Epidural Spine Injections Policy

Tuesday, September 18, 2018  
Share |

On September 12, 2018, SIS again submitted comments on Blue Shield of California’s coverage policy Epidural Spine Injections, which classifies full anticoagulation as a contraindication for epidural injections. SIS reiterates that while evidence has demonstrated a risk of hemorrhagic complications in anticoagulated patients undergoing interlaminar ESI, the same cannot be said for lumbar transforaminal epidural steroid injections. For lumbar transforaminal injections, there may actually be more risk in discontinuing anticoagulants, increasing the risk for cardiovascular or cerebrovascular events.


Contact Us

120 E. Ogden Ave. Ste. 202
Hinsdale, Illinois 60521
P: 630.203.2252
Toll Free: 888.255.0005

© Copyright 2016 Spine Intervention Society Privacy Policy  ::  Legal